Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19
Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicinePandemic2019-20 coronavirus outbreakValsartanIntensive care medicineSacubitril, ValsartanPharmacologyVirologyInternal medicineDiseaseInfectious disease (medical specialty)Blood pressureOutbreakCOVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsSARS-CoV-2 and COVID-19 Research